Cite
HARVARD Citation
Komaki, Y. et al. (2021). Infliximab therapy intensification based on endoscopic activity is related to suppress treatment discontinuation in patients with Crohn disease. Medicine. 100 (6), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Komaki, Y. et al. (2021). Infliximab therapy intensification based on endoscopic activity is related to suppress treatment discontinuation in patients with Crohn disease. Medicine. 100 (6), p. . [Online].